- call +1-201-465-4211
- email sales@mrinsights.biz
Neuro-oncological diseases are the disorders that are typically caused due to the growth of a benign or malignant tumor in the brain or any part of the central nervous system. Neuro-oncological tumors are highly fatal, and so their diagnosis becomes a topic of foremost importance. There are a number of neuro-oncological diagnosis devices based on a variety of techniques for the diagnosis of neuro-oncological diseases.
Scope of the Report:
This report focuses on the Neuro-Oncological Diseases Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The market for neuro-oncological diagnosis devices is most developed in the North American and European region owing to the funds that government provides for research and development of high-quality neuro-oncological diagnosis devices. The market for the devices is also increasing rapidly in Asia Pacific due to new policies of governments which fascinates manufacturers for manufacturing neuro-oncological diagnosis devices in these countries. Neuro-oncological diagnosis device usage is obligatory in the diagnosis of fatal diseases. Therefore, many under-developed economies of middle east and Africa also have a large market for neuro-oncological diagnosis devices.
The worldwide market for Neuro-Oncological Diseases Device is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Siemens Healthcare
Philips Healthcare
Toshiba Medical
GE Healthcare
Hitachi Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
MRI
CT Scan
PET
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
There are 15 Chapters to deeply display the global Neuro-Oncological Diseases Device market.
Chapter 1, to describe Neuro-Oncological Diseases Device Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Neuro-Oncological Diseases Device, with sales, revenue, and price of Neuro-Oncological Diseases Device, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Neuro-Oncological Diseases Device, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Neuro-Oncological Diseases Device market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Neuro-Oncological Diseases Device sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Neuro-Oncological Diseases Device Introduction
1.2 Market Analysis by Type
1.2.1 MRI
1.2.2 CT Scan
1.2.3 PET
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Diagnostics Centers
1.3.4 Reference Laboratories
1.3.5 Medical Research Institutes
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Siemens Healthcare
2.1.1 Business Overview
2.1.2 Neuro-Oncological Diseases Device Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Siemens Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Philips Healthcare
2.2.1 Business Overview
2.2.2 Neuro-Oncological Diseases Device Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Philips Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Toshiba Medical
2.3.1 Business Overview
2.3.2 Neuro-Oncological Diseases Device Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Toshiba Medical Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GE Healthcare
2.4.1 Business Overview
2.4.2 Neuro-Oncological Diseases Device Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GE Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hitachi Medical
2.5.1 Business Overview
2.5.2 Neuro-Oncological Diseases Device Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hitachi Medical Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neuro-Oncological Diseases Device Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Neuro-Oncological Diseases Device Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Neuro-Oncological Diseases Device Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuro-Oncological Diseases Device Manufacturer Market Share in 2017
3.3.2 Top 6 Neuro-Oncological Diseases Device Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Neuro-Oncological Diseases Device Market Analysis by Regions
4.1 Global Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Regions
4.1.1 Global Neuro-Oncological Diseases Device Sales and Market Share by Regions (2013-2018)
4.1.2 Global Neuro-Oncological Diseases Device Revenue and Market Share by Regions (2013-2018)
4.2 North America Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
4.3 Europe Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
4.5 South America Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
5 North America Neuro-Oncological Diseases Device by Countries
5.1 North America Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Countries
5.1.1 North America Neuro-Oncological Diseases Device Sales and Market Share by Countries (2013-2018)
5.1.2 North America Neuro-Oncological Diseases Device Revenue and Market Share by Countries (2013-2018)
5.2 United States Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
5.3 Canada Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
5.4 Mexico Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
6 Europe Neuro-Oncological Diseases Device by Countries
6.1 Europe Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Countries
6.1.1 Europe Neuro-Oncological Diseases Device Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Neuro-Oncological Diseases Device Revenue and Market Share by Countries (2013-2018)
6.2 Germany Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
6.3 UK Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
6.4 France Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
6.5 Russia Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
6.6 Italy Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
7 Asia-Pacific Neuro-Oncological Diseases Device by Countries
7.1 Asia-Pacific Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neuro-Oncological Diseases Device Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Neuro-Oncological Diseases Device Revenue and Market Share by Countries (2013-2018)
7.2 China Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
7.3 Japan Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
7.4 Korea Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
7.5 India Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
8 South America Neuro-Oncological Diseases Device by Countries
8.1 South America Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Countries
8.1.1 South America Neuro-Oncological Diseases Device Sales and Market Share by Countries (2013-2018)
8.1.2 South America Neuro-Oncological Diseases Device Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
8.3 Argentina Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
8.4 Colombia Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
9 Middle East and Africa Neuro-Oncological Diseases Device by Countries
9.1 Middle East and Africa Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Neuro-Oncological Diseases Device Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Neuro-Oncological Diseases Device Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
9.3 UAE Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
9.4 Egypt Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
9.5 Nigeria Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
9.6 South Africa Neuro-Oncological Diseases Device Sales and Growth Rate (2013-2018)
10 Global Neuro-Oncological Diseases Device Market Segment by Type
10.1 Global Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Neuro-Oncological Diseases Device Sales and Market Share by Type (2013-2018)
10.1.2 Global Neuro-Oncological Diseases Device Revenue and Market Share by Type (2013-2018)
10.2 MRI Sales Growth and Price
10.2.1 Global MRI Sales Growth (2013-2018)
10.2.2 Global MRI Price (2013-2018)
10.3 CT Scan Sales Growth and Price
10.3.1 Global CT Scan Sales Growth (2013-2018)
10.3.2 Global CT Scan Price (2013-2018)
10.4 PET Sales Growth and Price
10.4.1 Global PET Sales Growth (2013-2018)
10.4.2 Global PET Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Neuro-Oncological Diseases Device Market Segment by Application
11.1 Global Neuro-Oncological Diseases Device Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Diagnostics Centers Sales Growth (2013-2018)
11.5 Reference Laboratories Sales Growth (2013-2018)
11.6 Medical Research Institutes Sales Growth (2013-2018)
11.7 Others Sales Growth (2013-2018)
12 Neuro-Oncological Diseases Device Market Forecast (2018-2023)
12.1 Global Neuro-Oncological Diseases Device Sales, Revenue and Growth Rate (2018-2023)
12.2 Neuro-Oncological Diseases Device Market Forecast by Regions (2018-2023)
12.2.1 North America Neuro-Oncological Diseases Device Market Forecast (2018-2023)
12.2.2 Europe Neuro-Oncological Diseases Device Market Forecast (2018-2023)
12.2.3 Asia-Pacific Neuro-Oncological Diseases Device Market Forecast (2018-2023)
12.2.4 South America Neuro-Oncological Diseases Device Market Forecast (2018-2023)
12.2.5 Middle East and Africa Neuro-Oncological Diseases Device Market Forecast (2018-2023)
12.3 Neuro-Oncological Diseases Device Market Forecast by Type (2018-2023)
12.3.1 Global Neuro-Oncological Diseases Device Sales Forecast by Type (2018-2023)
12.3.2 Global Neuro-Oncological Diseases Device Market Share Forecast by Type (2018-2023)
12.4 Neuro-Oncological Diseases Device Market Forecast by Application (2018-2023)
12.4.1 Global Neuro-Oncological Diseases Device Sales Forecast by Application (2018-2023)
12.4.2 Global Neuro-Oncological Diseases Device Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Neuro-Oncological Diseases Device Picture
Table Product Specifications of Neuro-Oncological Diseases Device
Figure Global Sales Market Share of Neuro-Oncological Dis
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
